Pfizer to submit Covid pill to FDA before Thanksgiving, says CEO Albert Bourla

Pfizer CEO Albert Bourla sits down with CNBC's 'Squawk Box' and Meg Tirrell to discuss the company's oral Covid-19 antiviral, which was found to cut the risk of hospitalization and death by 89% in high-risk adults.